These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase. Markianos M; Tripodianakis J; Garelis E Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia. Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699 [TBL] [Abstract][Full Text] [Related]
7. A biochemical study of tardive dyskinesia in young male patients. Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438 [TBL] [Abstract][Full Text] [Related]
8. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients]. Xavier Vieira R; Azevedo M; Polónio P; Manso C Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081 [No Abstract] [Full Text] [Related]
11. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia. Wyatt RJ; Murphy DL Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116 [No Abstract] [Full Text] [Related]
12. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland]. Gałecki P; Pietras T; Szemraj J Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237 [TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641 [TBL] [Abstract][Full Text] [Related]
14. [Blood MAO/DBH index and the results of the treatment of endogenous depression]. Puzyński S; Hauptmann M; Rode A; Kalinowski A; Bidzińska E; Beresewicz M; Bidziński A Psychiatr Pol; 1990; 24(3):202-8. PubMed ID: 2084728 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
16. Serum DBH and platelet MAO in patients with depressive disorders. Honecker H; Fähndrich E; Coper H; Helmchen H Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043 [TBL] [Abstract][Full Text] [Related]
17. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia. Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853 [TBL] [Abstract][Full Text] [Related]
18. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia]. Gałecki P; Pietras T; Florkowki A Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180 [TBL] [Abstract][Full Text] [Related]
19. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169 [TBL] [Abstract][Full Text] [Related]
20. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]